.png)
Our mission is to support research efforts to achieve the primary prevention
of breast and ovarian cancers. The focus of our efforts is to obtain
federal funding for a “Women’s Health Initiative” to facilitate
clinical trials for the primary immune prevention
of breast and ovarian cancer in otherwise healthy, cancer-free women.
The Cost of Clinical Trials
Why are Funds Needed?
​
$7 million – Completion of two phase I clinical trials for primary prevention of ovarian cancer OR triple negative breast cancer (TNBC)
​
$13-20 mil – Completion of a small phase II trial for primary prevention of ovarian cancer OR TNBC
$50-100 mil – Completion of a multi-center phase III efficacy trial for primary prevention of either ovarian cancer or TNBC
​
Spending last year by the NCI's Division of Cancer Treatment and Diagnosis was $332.7 million more than spending by the Division of Cancer Prevention.
What is Needed:
At least $332.7 million to the Division of Cancer Prevention to eliminate the treatment bias and make both equivalent and to provide that money for support of primary prevention clinical trials.